Dharamvir Jain, M.D.

Dharamvir Jain, M.D.

Dharamvir Jain, M.D.

Dharamvir Jain, M.D.

  • Associate Professor of Medicine
James Graham Brown Cancer Center
529 South Jackson Street
Louisville, KY 40202

502-852-2522 - Academic Office
502-562-4370 - Patient Appointments


Clinical Expertise
Hematology and Oncology - Breast Health

 

Education and Training

  • Medical School: Maulana Azad Medical College, University of Delhi
  • Residency: Maulana Azad Medical College, University of Delhi; Bronx Lebanon Hospital Center, Albert Einstein College of Medicine
  • Fellowship: Our Lady of Mercy Medical Center; New York Medical College

 

Recent Publications

        • Liu M, Luo F, Ding C, Albeituni S, Hu X, Ma Y, Cai Y, McNally L, Sanders MA, Jain D, Kloecker G, Bousamra M 2nd, Zhang HG, Higashi RM, Lane AN, Fan TW, Yan J. Dectin-1 Activation by a Natural Product β-Glucan Converts Immunosuppressive Macrophages into an M1-like Phenotype. J Immunol. 2015 Nov 15;195(10):5055-65. doi: 10.4049/jimmunol.1501158. Epub 2015 Oct 9. PubMed PMID: 26453753; PubMed Central PMCID: PMC4637216.
        • Shaughnessy JN, Meena RA, Dunlap NE, Jain D, Riley EC, Quillo AR, Dragun AE. Efficacy of concurrent chemoradiotherapy for patients with locally recurrent or advanced inoperable breast cancer. Clin Breast Cancer. 2015 Apr;15(2):135-42. doi: 10.1016/j.clbc.2014.10.007. Epub 2014 Oct 22. PubMed PMID: 25454741.
        • Barry PN, Riley EC, Pan J, Crew JB, Lee K, Jain D, Kruse B, Quillo AR, Rai S, Dragun AE. Delay of adjuvant chemotherapy after elective mastectomy and immediate reconstruction in breast-conservation candidates: a matched-pair analysis. Am J Clin Oncol. 2014 Dec;37(6):575-9. doi: 10.1097/COC.0b013e318280d79f. PubMed PMID: 23466579.
        • Dias AL, Jain D. Ibrutinib: a new frontier in the treatment of chronic lymphocytic leukemia by Bruton's tyrosine kinase inhibition. Cardiovasc Hematol Agents Med Chem. 2013 Dec;11(4):265-71. Review. PubMed PMID: 24433470; PubMed Central PMCID: PMC4010045.
        • Dragun AE, Pan J, Riley EC, Kruse B, Wilson MR, Rai S, Jain D. Increasing use of elective mastectomy and contralateral prophylactic surgery among breast conservation candidates: a 14-year report from a comprehensive cancer center. Am J Clin Oncol. 2013 Aug;36(4):375-80. doi: 10.1097/COC.0b013e318248da47. PubMed PMID: 22643566.
        • Dragun AE, Quillo AR, Riley EC, Roberts TL, Hunter AM, Rai SN, Callender GG, Jain D, McMasters KM, Spanos WJ. A phase 2 trial of once-weekly hypofractionated breast irradiation: first report of acute toxicity, feasibility, and patient satisfaction. Int J Radiat Oncol Biol Phys. 2013 Mar 1;85(3):e123-8. doi: 10.1016/j.ijrobp.2012.10.021. Epub 2012 Nov 27. PubMed PMID: 23195779.
        • Dragun AE, Pan J, Rai SN, Kruse B, Jain D. Locoregional recurrence in patients with triple-negative breast cancer: preliminary results of a single institution study. Am J Clin Oncol. 2011 Jun;34(3):231-7. doi: 10.1097/COC.0b013e3181dea993. PubMed PMID: 20805742.
        • Hargis JB, Jain D. Systemic therapy for early breast cancer. J Ky Med Assoc. 2009 Oct;107(10):401-6. PubMed PMID: 19873798.
        • Weinel S, Malone J, Jain D, Callen JP. Leukaemia cutis in a patient treated for breast cancer. Australas J Dermatol. 2009 Feb;50(1):52-5. doi: 10.1111/j.1440-0960.2008.00504.x. PubMed PMID: 19178494.
        • Weinel S, Malone J, Jain D, Callen JP. Therapy-related leukaemia cutis: a review. Australas J Dermatol. 2008 Nov;49(4):187-90. doi: 10.1111/j.1440-0960.2008.00466.x. Review. PubMed PMID: 18855778.